Delivery Order SPE2DR25D2014-SPE2DR26FA5X3

<p>The Defense Logistics Agency issued a $30,162.18 delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for Injectafer 750 mg/15 ml vials.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 3, 2026, and is priced on a firm fixed-price basis. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $6,249.40 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Injectafer 750 mg/15 ml vial pharmaceutical product, with an ultimate completion date of February 11, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside designation.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 17, 2026, with a ceiling value of $37,231.46 for Injectafer 750 mg/15 ml vials under firm fixed pricing.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is February 18, 2026. The order was issued on a no-set-aside basis.</p>

The Defense Logistics Agency issued a $2,618.35 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Injectafer 750 mg/15 mL vials. The order is placed against the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order carries a firm fixed price...

The Defense Logistics Agency awarded a $18,473.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on January 7, 2026, with a completion date of January 8, 2026. The place of performance is located in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open competition. AmerisourceBergen Drug...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,260.48 to supply Injectafer 750 mg/15 mL vials. The order, issued on December 18, 2025, with completion targeted for December 19, 2025, represents a firm fixed price delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfilled this requirement as part of its federal pharmaceutical supply portfolio serving military and veteran...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,075.62 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Injectafer is an intravenous iron replacement therapy used in the treatment of iron...

The Defense Logistics Agency awarded a delivery order valued at $9,850.87 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This competitively awarded, firm fixed price delivery order was executed on December 22, 2025, with an ultimate completion date of December 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation, indicating the award was made through open...

The Defense Logistics Agency awarded a delivery order valued at $7,304.98 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on November 14, 2025, with completion scheduled for November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...

The Defense Logistics Agency awarded a delivery order valued at $10,913.07 to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Injectafer 750 mg/15 ml vials. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by December 24, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...